Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.78 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.78 |
| ▸ | ERN1 | O75460 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CDK4 | P11802 | 1/20 | 0.50 |
| ▸ | CCND1 | P24385 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.45 |
| ▸ | JUN | P05412 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | NAT1 | P18440 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicyladehyde SCHEMBL6694640 | 0.92 | TRIM24 (0.67) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL28887959 | 0.91 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL6917405 | 0.91 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL27901835 | 0.89 | TRIM24 (0.62) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL29386538 | 0.89 | — | — | |
| Salicyladehyde SCHEMBL15395 | 0.89 | — | — | |
| Salicyladehyde SCHEMBL901265 | 0.89 | TRIM24 (1.00) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL23389487 | 0.86 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL1176891 | 0.86 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNACDK4 | |
| Salicyladehyde SCHEMBL5842615 | 0.86 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNACDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6392093-B1 | USING OXIDATION CATALYST | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2002-05-21 | — | — | US | claimed |
| US-8268048-B2 | Oxygen binding of nanoparticulate metal complexes | UNIVERSITY OF KANSAS (US) | 2012-09-18 | — | — | US | disclosed |
| US-20100089236-A1 | Oxygen Binding of Nanoparticulate Metal Complexes | NATIONAL SCIENCE FOUNDATION | 2010-04-15 | — | — | US | disclosed |
| US-20070134338-A1 | Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology | KANSAS UNIVERSITY OF, THE | 2007-06-14 | — | — | US | disclosed |
| US-5250486-A | Catalyst comprising a manganese compound, a chelate compound, a base and an unsaturated ketone or ether; controlled molecular weight; odorless; stabile thermal properties when blended with styrene resins | GENERAL ELECTRIC COMPANY (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0491190-A2 | Polyphenylene ether process and resin composition | GENERAL ELECTRIC COMPANY (US) | 1992-06-24 | — | — | EP | disclosed |
| US-5037943-A | Oxidative coupling using alkaline catalysts system of manganese chelate and unsaturated or diketune or vinyl ether | GENERAL ELECTRIC CO. (US) | 1991-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070134338-A1 | Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology | NCSTN, NCLN, NCDN | TRIM24 3441/4885TRIM33 3361/4885ERN1 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.